Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)

Name: Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)
License: Public Domain

The United Bio-Technology (Hengqin) Co., Ltd.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

type 2 diabetes

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 405125
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.